Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anne Beall

Showing results (11-20 of 16) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 16 results.
G3 (Bethesda, Md.)|June 9, 2017
Allelic Variation in the Toll-Like Receptor Adaptor Protein <i>Ticam2</i> Contributes to SARS-Coronavirus Pathogenesis in MiceLisa E Gralinski, Vineet D Menachery, Andrew P Morgan, et al.
Frontiers in Pharmacology|December 19, 2022
Inhibition of coronavirus HCoV-OC43 by targeting the eIF4F complexYongmei Feng, Stefan Grotegut, Predrag Jovanovic, et al.
Frontiers in Pharmacology|January 3, 2025
Corrigendum: Inhibition of coronavirus HCoV-OC43 by targeting the eIF4F complexYongmei Feng, Stefan Grotegut, Predrag Jovanovic, et al.
Mbio|August 24, 2017
MERS-CoV Accessory ORFs Play Key Role for Infection and PathogenesisVineet D Menachery, Hugh D Mitchell, Adam S Cockrell, et al.
ACS Infectious Diseases|June 29, 2022
Sec61 Inhibitor Apratoxin S4 Potently Inhibits SARS-CoV-2 and Exhibits Broad-Spectrum Antiviral ActivityMarie O Pohl, Laura Martin-Sancho, Ranjala Ratnayake, et al.
Pathogens (Basel, Switzerland)|December 22, 2023
The Therapeutic Monoclonal Antibody Bamlanivimab Does Not Enhance SARS-CoV-2 Infection by FcR-Mediated MechanismsRobert W Cross, Christopher M Wiethoff, Patricia Brown-Augsburger, et al.
Pageof 2

Showing results (11-20 of 16) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 16 results.
G3 (Bethesda, Md.)|June 9, 2017
Allelic Variation in the Toll-Like Receptor Adaptor Protein <i>Ticam2</i> Contributes to SARS-Coronavirus Pathogenesis in MiceLisa E Gralinski, Vineet D Menachery, Andrew P Morgan, et al.
Frontiers in Pharmacology|December 19, 2022
Inhibition of coronavirus HCoV-OC43 by targeting the eIF4F complexYongmei Feng, Stefan Grotegut, Predrag Jovanovic, et al.
Frontiers in Pharmacology|January 3, 2025
Corrigendum: Inhibition of coronavirus HCoV-OC43 by targeting the eIF4F complexYongmei Feng, Stefan Grotegut, Predrag Jovanovic, et al.
Mbio|August 24, 2017
MERS-CoV Accessory ORFs Play Key Role for Infection and PathogenesisVineet D Menachery, Hugh D Mitchell, Adam S Cockrell, et al.
ACS Infectious Diseases|June 29, 2022
Sec61 Inhibitor Apratoxin S4 Potently Inhibits SARS-CoV-2 and Exhibits Broad-Spectrum Antiviral ActivityMarie O Pohl, Laura Martin-Sancho, Ranjala Ratnayake, et al.
Pathogens (Basel, Switzerland)|December 22, 2023
The Therapeutic Monoclonal Antibody Bamlanivimab Does Not Enhance SARS-CoV-2 Infection by FcR-Mediated MechanismsRobert W Cross, Christopher M Wiethoff, Patricia Brown-Augsburger, et al.
Pageof 2